Atlas Trials

A Study of XmAb®18087 in Subjects With NET and GIST

Clinical trial NCT03411915 · COMPLETED

Trial details

NCT number
NCT03411915
Sponsor
Xencor, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine TumorGastrointestinal Neoplasm
Start date
2018-01-22
Primary completion
2021-10-26
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.